Home>B7-H3 chimeric antigen receptor-modified T cell shows potential for targeted treatment of acute myeloid leukaemia
B7-H3 chimeric antigen receptor-modified T cell shows potential for targeted treatment of acute myeloid leukaemia
- Impact factors: 4.981
- Publication: EUROPEAN JOURNAL OF MEDICAL RESEARCH
- Author:Fan Shuangshuang, Wang Tian, You Fengtao, Zhang Tingting, Li Yafen, Ji Cheng, Han Zhichao, Sheng Binjie, Zhai Xiaochen, An Gangli, Meng Huimin, Yang Lin
- DOI citation-doi:10.1186/s40001-023-01049-y
- Date:2023-03-20